Investment Firm
Overview
A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.
Nov 15, 2017
Nov 20, 2017
Post Ipo Equity
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Achillion Pharmaceuticals raised $50510201 on 2017-11-15 in Post-IPO Equity
A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.
Company Funding History
6
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jun 22, 2011 | Post-IPO Equity - Achillion Pharmaceuticals | - | 60.9M | |
Feb 27, 2013 | Post-IPO Equity - Achillion Pharmaceuticals | - | 133.5M | |
Jan 28, 2002 | Venture Round - Achillion Pharmaceuticals | 10 | - | 41.0M |
Aug 18, 2010 | Post-IPO Equity - Achillion Pharmaceuticals | 4 | - | 50.1M |